European Leukemia Trial Registry
Trial: ALL GMALL 07/2003

More Details
Title Therapy optimization by MRD-evaluation
Scientific Title Multicenter Study To Optimize Treatment of Acute Lymphoblastic Leukemia in Adults (> 18 years)- Treatment Optimization by Evaluation of Minimal Residual Disease
Short Title ALL GMALL 07/2003
Trialgroup GMALL
Type of Trial multicentric
Disease Acute lymphoblastic leukemia(ALL) All subtypes
Age <= 65 years (55-65 years if biologically younger)
Status No longer recruiting
Start of Recruitment 01.04.2003
Leader Gökbuget, Dr. med., Nicola
Contactperson

Study Physician
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Study Centre
Reutzel, Regina
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301-7463
Email: reutzel@em.uni-frankfurt.de

Biometrics
Messerer, Dr. rer. nat., Dorle
Tel: +49 (0)911 630479
Fax: +49 (0)911 639127
Email: dorle@messerer.com

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
Diagnostics

Molecular Genetics
Hämatologie Labor Kiel, Klinik für Innere Medizin II, UKSH, Kiel
Molekulargenetik-Labor der Med.Klinik II, Universitätsklinikum Frankfurt

Immunophaenotyping
Immunologisches Markerlabor der Charité Berlin, Campus Benjamin-Franklin

Cytogenetics
Tumorzytogenetik-Labor, Universität Düsseldorf

Remark Amendment I from 18. August 2004; Amendment II from 12. September 2006 Amendment III from 17. December 2007; Amendment IV from 29. December 2008 Amendment from 20. August 2009; Amendment 6 from 30.June 2010
created 31.05.2006 Anja Hellenbrecht
changed 18.07.2017 Eva-Maria Ableidinger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org